# FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)

> **NCT01524705** · PHASE4 · COMPLETED · sponsor: **University of Washington** · enrollment: 102 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Insulin Glargine
- **DRUG:** Metformin
- **DRUG:** Prandial insulin
- **DRUG:** Exenatide

## Key facts

- **NCT ID:** NCT01524705
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2023-12-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01524705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01524705, "FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01524705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*